Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome
- 8 June 2019
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 18 (8), 778-785
- https://doi.org/10.1016/j.autrev.2019.06.008
Abstract
No abstract availableKeywords
Funding Information
- Società Italiana di Malattie Infettive e Tropicali
This publication has 77 references indexed in Scilit:
- Life-Threatening Cryoglobulinemic Patients With Hepatitis CMedicine, 2013
- The vasculitic neuropathiesCurrent Opinion in Neurology, 2012
- HCV-Related Nervous System DisordersJournal of Immunology Research, 2012
- Vasculitic emergencies in the intensive care unit: a special focus on cryoglobulinemic vasculitisAnnals of Intensive Care, 2012
- Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas surveyBlood, 2012
- Central nervous system vasculitis and polyneuropathy as first manifestations of hepatitis CWorld Journal of Gastroenterology, 2012
- A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus–associated cryoglobulinemic vasculitisArthritis & Rheumatism, 2011
- Successful combination of Rituximab and plasma exchange in the treatment of cryoglobulinemic vasculitis with skin ulcers: a case reportCases Journal, 2009
- Mixed cryoglobulinemiaOrphanet Journal of Rare Diseases, 2008
- Efficacy and safety of rituximab in type II mixed cryoglobulinemiaBlood, 2003